Status:
NOT_YET_RECRUITING
Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology
Lead Sponsor:
Henan Cancer Hospital
Collaborating Sponsors:
Xinyang Central Hospital
Guangdong Provincial People's Hospital
Conditions:
Esophageal Cancer
Neoadjuvant Therapy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this clinical study is to conduct a multi-center, big data study to create a neural network decision model for predicting treatment efficacy and prognosis based on multi-modal, multi-te...
Eligibility Criteria
Inclusion
- Aged 18-70 years;
- Histologically confirmed esophageal carcinoma by biopsy;
- No prior antitumor therapy received.
Exclusion
- Contraindications to MRI examination;
- Poor compliance with antitumor therapy;
- Unwillingness to participate in the study;
- Image quality inadequate for diagnostic requirements.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT07203690
Start Date
December 1 2025
End Date
December 1 2027
Last Update
October 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.